PSQ Holdings, Inc. (PSQH) - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. PSQ Holdings, Inc. (dba PublicSquare) operates as a technology-enabled Marketplace and Payments ecosystem with three segments: Financial Technology (Credova BNPL and PSQ Payments), Marketplace (e-commerce and advertising), and Brands (EveryLife baby products). The company is classified as a smaller reporting company and an emerging growth company.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenues, Net | $6.75 million | $3.47 million |
| Net Loss | $(4.45) million | $(12.58) million |
| Operating Loss | $(11.69) million | $(14.91) million |
| Cash and Cash Equivalents | $28.04 million | $9.11 million |
| Net Cash Used in Operating Activities | $(6.43) million | $(6.52) million |
| Revolving Line of Credit (Outstanding) | $3.70 million | $3.78 million |
| Convertible Promissory Notes | $28.45 million | $28.45 million |
Note: Net loss improvement was significantly driven by a $7.38 million non-cash gain from the change in fair value of warrant liabilities.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 95% year-over-year to $6.75 million, driven by a 709% increase in Financial Technology revenue (to $3.05 million) and a 52% increase in Brands revenue (to $3.27 million). Marketplace revenue declined 55% to $0.43 million.
- Expense Management: Sales and marketing expenses decreased 48% to $2.46 million due to reduced share-based compensation and advertising spend. However, depreciation and amortization increased 308% to $1.21 million due to capitalized software costs.
- Non-GAAP Performance: Non-GAAP operating loss narrowed to $4.88 million from $1.96 million in the prior year, reflecting higher segment revenues offset by increased corporate costs and share-based compensation.
- GMV Trends: Financial Technology Gross Merchandise Volume (GMV) for credit products declined 33% to $11.4 million, attributed to a slowdown in the firearm retail industry and tighter underwriting standards. Conversely, PSQ Payments GMV was $36.0 million (new segment launched in late 2024).
Outlook, Risks, and Unusual Items
- Liquidity: Management believes existing cash ($28.0 million) is sufficient to fund operations for the next 12 months. However, the company may need to raise additional equity or debt financing in the future.
- Regulatory Risk: Credova is responding to inquiries from the Consumer Financial Protection Bureau (CFPB) regarding its lease products. The CFPB has suggested injunctive relief, and the company cannot assure a settlement will be reached or quantify potential penalties.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2025, due to a material weakness in the preparation of the statement of cash flows. Remediation steps include hiring additional staff and automating processes.
- Subsequent Events: In April 2025, the company acquired software assets for 2 million shares of Class A common stock and potential earn-outs of up to $1.25 million. A new 37-month office lease was also signed.
Investor Verification Checklist
- Warrant Liability Volatility: Verify the sensitivity of the $7.38 million gain in warrant liabilities to stock price fluctuations, as this significantly masks the underlying operating loss.
- CFPB Inquiry Status: Monitor updates on the CFPB investigation into Credova's lease products for potential fines or operational restrictions.
- Cash Burn Rate: Assess the sustainability of the $6.4 million quarterly operating cash burn against the $28 million cash balance, considering the need for future capital raises.
- Remediation of Material Weakness: Review future filings to confirm the effectiveness of remediation steps regarding the material weakness in internal controls over financial reporting.
- FinTech GMV Concentration: Note that the top five merchants represented 58% of FinTech credit GMV, with the largest single merchant at 23%, indicating high concentration risk.